Atlas Trials

Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults

Clinical trial NCT01491607 · COMPLETED

Trial details

NCT number
NCT01491607
Sponsor
Emergent BioSolutions
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Anthrax
Start date
2011-11-01
Primary completion
2012-05-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.